BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 22331798)

  • 41. High WT1 expression after induction therapy predicts high risk of relapse and death in pediatric acute myeloid leukemia.
    Lapillonne H; Renneville A; Auvrignon A; Flamant C; Blaise A; Perot C; Lai JL; Ballerini P; Mazingue F; Fasola S; Dehée A; Bellman F; Adam M; Labopin M; Douay L; Leverger G; Preudhomme C; Landman-Parker J
    J Clin Oncol; 2006 Apr; 24(10):1507-15. PubMed ID: 16575000
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Insights into cell ontogeny, age, and acute myeloid leukemia.
    Chaudhury SS; Morison JK; Gibson BE; Keeshan K
    Exp Hematol; 2015 Sep; 43(9):745-55. PubMed ID: 26051919
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Decreased DNA methylation in acute myeloid leukemia patients with DNMT3A mutations and prognostic implications of DNA methylation.
    Hájková H; Marková J; Haškovec C; Sárová I; Fuchs O; Kostečka A; Cetkovský P; Michalová K; Schwarz J
    Leuk Res; 2012 Sep; 36(9):1128-33. PubMed ID: 22749068
    [TBL] [Abstract][Full Text] [Related]  

  • 44. tp53-dependent G2 arrest mediator candidate gene, Reprimo, is down-regulated by promoter hypermethylation in pediatric acute myeloid leukemia.
    Tao YF; Li ZH; Wang NN; Fang F; Xu LX; Pan J
    Leuk Lymphoma; 2015; 56(10):2931-44. PubMed ID: 25629980
    [TBL] [Abstract][Full Text] [Related]  

  • 45. CTNNA1 hypermethylation, a frequent event in acute myeloid leukemia, is independently associated with an adverse outcome.
    Li M; Gao L; Li Z; Sun J; Zhang H; Duan H; Ma Y; Wang C
    Oncotarget; 2016 May; 7(21):31454-65. PubMed ID: 27129146
    [TBL] [Abstract][Full Text] [Related]  

  • 46. CHFR hypermethylation, a frequent event in acute myeloid leukemia, is independently associated with an adverse outcome.
    Gao L; Liu F; Zhang H; Sun J; Ma Y
    Genes Chromosomes Cancer; 2016 Feb; 55(2):158-68. PubMed ID: 26542416
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of promoter DNA methylation and expression levels of genes encoding CCAAT/enhancer binding proteins in AML patients.
    Musialik E; Bujko M; Kober P; Grygorowicz MA; Libura M; Przestrzelska M; Juszczyński P; Borg K; Florek I; Jakóbczyk M; Baranowska A; Siedlecki JA
    Leuk Res; 2014 Jul; 38(7):850-6. PubMed ID: 24878001
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A noncanonical Flt3ITD/NF-κB signaling pathway represses DAPK1 in acute myeloid leukemia.
    Shanmugam R; Gade P; Wilson-Weekes A; Sayar H; Suvannasankha A; Goswami C; Li L; Gupta S; Cardoso AA; Baghdadi TA; Sargent KJ; Cripe LD; Kalvakolanu DV; Boswell HS
    Clin Cancer Res; 2012 Jan; 18(2):360-369. PubMed ID: 22096027
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hypermethylation and down-regulation of DLEU2 in paediatric acute myeloid leukaemia independent of embedded tumour suppressor miR-15a/16-1.
    Morenos L; Chatterton Z; Ng JL; Halemba MS; Parkinson-Bates M; Mechinaud F; Elwood N; Saffery R; Wong NC
    Mol Cancer; 2014 May; 13():123. PubMed ID: 24885794
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Allele-specific expression of GATA2 due to epigenetic dysregulation in CEBPA double-mutant AML.
    Mulet-Lazaro R; van Herk S; Erpelinck C; Bindels E; Sanders MA; Vermeulen C; Renkens I; Valk P; Melnick AM; de Ridder J; Rehli M; Gebhard C; Delwel R; Wouters BJ
    Blood; 2021 Jul; 138(2):160-177. PubMed ID: 33831168
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Epigenetic aberrations in acute myeloid leukemia: Early key events during leukemogenesis.
    Eriksson A; Lennartsson A; Lehmann S
    Exp Hematol; 2015 Aug; 43(8):609-24. PubMed ID: 26118500
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mutant WT1 is associated with DNA hypermethylation of PRC2 targets in AML and responds to EZH2 inhibition.
    Sinha S; Thomas D; Yu L; Gentles AJ; Jung N; Corces-Zimmerman MR; Chan SM; Reinisch A; Feinberg AP; Dill DL; Majeti R
    Blood; 2015 Jan; 125(2):316-26. PubMed ID: 25398938
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Aberrant methylation of the promoter regions of the SOX7 and p15INK4b genes and Wnt signaling pathway antagonists in patients with acute myeloid leukemias].
    Kostroma II; Gritsaev SV; Sidorova ZY; Tiranova SA; Svitina SP; Drizhun YS; Chubukina ZV; Martynkevich IS; Kapustin SI; Bessmeltsev SS
    Ter Arkh; 2016; 88(7):31-36. PubMed ID: 27459612
    [TBL] [Abstract][Full Text] [Related]  

  • 54. MOK overexpression is associated with promoter hypomethylation in patients with acute myeloid leukemia.
    Qian J; Chen Q; Yao DM; Yang L; Yang J; Wen XM; Zhang YY; Chai HY; Ma JC; Deng ZQ; Lin J
    Int J Clin Exp Pathol; 2015; 8(1):127-36. PubMed ID: 25755699
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The increasing genomic complexity of acute myeloid leukemia.
    Rowe JM
    Best Pract Res Clin Haematol; 2014; 27(3-4):209-13. PubMed ID: 25455268
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Harnessing the potential of epigenetic therapies for childhood acute myeloid leukemia.
    Newcombe AA; Gibson BES; Keeshan K
    Exp Hematol; 2018 Jul; 63():1-11. PubMed ID: 29608923
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Abnormal methylation of GRAF promoter Chinese patients with acute myeloid leukemia.
    Qian J; Qian Z; Lin J; Yao DM; Chen Q; Li Y; Ji RB; Yang J; Xiao GF; Wang YL
    Leuk Res; 2011 Jun; 35(6):783-6. PubMed ID: 21074269
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification and validation of obesity-related gene LEP methylation as a prognostic indicator in patients with acute myeloid leukemia.
    Zhang TJ; Xu ZJ; Gu Y; Ma JC; Wen XM; Zhang W; Deng ZQ; Qian J; Lin J; Zhou JD
    Clin Epigenetics; 2021 Jan; 13(1):16. PubMed ID: 33485366
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical implications of genome-wide DNA methylation studies in acute myeloid leukemia.
    Li Y; Xu Q; Lv N; Wang L; Zhao H; Wang X; Guo J; Chen C; Li Y; Yu L
    J Hematol Oncol; 2017 Feb; 10(1):41. PubMed ID: 28153026
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Gene Expression Analysis of Pediatric Acute Myeloid Leukemia Identified a Hyperactive ASXL1/BAP1 Axis Linked with Poor Prognosis and over Expressed Epigenetic Modifiers.
    Elyamany G; Akhter A; Kamran H; Rizwan H; Shabani-Rad MT; Alkhayat N; Al Sharif O; Elborai Y; Al Shahrani M; Mansoor A
    Pediatr Hematol Oncol; 2021 Sep; 38(6):581-592. PubMed ID: 33764257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.